Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  4.42 10:33 AM EDT  
    Day High 4.69 09:34 AM EDT
    Range 0.27  
    Volume 146,695  
    30-Day Avg Vol 225,000
    Difference -34.80%  
    Market Cap 310.61 M  
    Mkt Cap Chg -14.49 M  
    Shares Out 69.02 M  
    % Shrs Traded 0.21%  
    1yr EPS Est -0.96  
    52-Wk Low 2.06 12/5/08
    52-Wk High 9.25 7/17/08
    Range 7.19  
    Prev Close 4.71 7/1/09  
    Today's Open 4.66  
    Change -1.06%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 3.92 M

    Performance Details

    Revenue (LFY) 73.98 M  
    Earnings (LFY) -116.24 M  
    Earnings (MRQ) -18.13 M  
    Next Earn Est -0.268  
    Next Earnings 08/05/2009
    EPS (TTM) -1.35  
    1yr EPS Growth 28.89%  
    P/E Ratio (TTM)  
    P/E Ratio (Fwd) -4.00  
    PEG Ratio  
    Return on Equity -167.70  
    Beta 1.12  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: ZGEN

    Blogs are not currently available for zgen.

    View all blogs at BloggingStocks.

  • Related Information: ZGEN

    Company Overview: ZGEN

    ZymoGenetics has proteins on its plate. The firm culls genomics databases to indentify and develop protein-based drugs targeting a variety conditions, including autoimmune diseases and cancer. Its sole ... View Full Description

    Earnings Analysis: ZGEN

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter -0.268 8/5/09
    Last Quarter -0.318 3/31/09 -0.26 3/31/09 0.058
    Beat
    2 Quarters Ago -0.465 12/31/08 -0.13 12/31/08 0.335
    Beat

    Financials: ZGEN

      Quarterly - 03/31/2009 Annual - 2008
    Total Revenue 24.84 M 73.99 M
    Gross Profit 21.99 M 61.14 M
    Operating Income -15.91 M -118.60 M
    Net Income -18.13 M -116.24 M